Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Add Yahoo as a preferred source to see more of our stories on Google. Roche has announced data from the open-label extension part of its Phase II trial of the BTK inhibitor. Image credit: Shutterstock ...
Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals ...
Results show that it may be beneficial to add longitudinal monitoring of kidney function to the management of patients with MDS. Myelodysplastic syndromes (MDS) are associated with a substantially ...
Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial. The single-site study randomized 60 people with early to ...
SUGAR LAND, Texas--(BUSINESS WIRE)--#biopharma--Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical ...
CAMBRIDGE, Mass., AUSTIN, Texas & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas Südhof, a ...
Study: Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease. Image Credit: mozakim / Shutterstock.com Parkinson’s disease (PD) is a neurodegenerative ...
A total of 155 PD patients were acquired from the Parkinson’s Disease Progression Marker Initiative (PPMI). Distinct longitudinal trajectory clusters of motor symptom progression in PD patients were ...
Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled Trial Myelodysplastic syndromes (MDS) ...
Microsoft today announced an artificial intelligence tool that outperformed a panel of medical doctors in diagnosing complicated cases. The Microsoft AI Diagnostic Orchestrator (MAI-DxO) faced off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results